Ruibo Biology-B (06938.HK) received an increase of 13,200 shares held by executive director Gan Liming.

Sinolink Financial News APP News, Ruibo Biotechnology-B (06938.HK) announced that the company's board of directors recently received notification from Dr. Gan Liming, the company's executive director and co-CEO and global chief research officer, that as of July 3, 2026, Dr. Gan had purchased a total of 13,200 H shares of the company using his own funds in the open market.